ICH Q9 Lifecycle Review: When to Revisit Old Risk Assessments


Published on 18/05/2026

Revising Old Risk Assessments in ICH Q9 Quality Risk Management

In pharmaceutical manufacturing, proactive risk management is essential to ensure product quality and compliance with regulatory standards. However, outdated risk assessments can lead to significant quality issues and regulatory non-compliance. This article focuses on the problem of outdated risk assessments within the quality risk management framework of ICH Q9, providing practical solutions for improvement.

By the end of this article, you will understand the symptoms of inadequate risk assessment reviews, the likely causes for these failures, immediate containment actions you can take, and a comprehensive investigation workflow to uncover the root causes. You’ll also gain insights into establishing a robust CAPA strategy and maintaining inspection readiness.

Symptoms/Signals on the Floor or in the Lab

The first step in addressing outdated risk assessments is identifying the symptoms that indicate a problem. These may include:

  • Increased Deviations: A noticeable rise in incidents or deviations related to quality issues could signal that risk assessments
have not been updated to reflect current processes or materials.
  • New Regulatory Insights: Emerging guidance from authorities such as the FDA or EMA suggesting new risk controls may reveal deficiencies in existing assessments.
  • Frequent CAPA Activities: An influx of corrective actions could indicate that controls considered in previous risk assessments are no longer adequate or effective.
  • Stakeholder Feedback: Inputs from teams during regular meetings or audits may highlight concerns regarding the relevance of certain risk assessments.
  • Awareness of these signals is critical, as they provide the initial data needed to initiate a comprehensive review.

    Likely Causes

    Identifying the root causes of inadequate risk assessments is essential for effective remediation. Common causes can generally be categorized as follows:

    Category Likely Causes
    Materials Change in suppliers, introduction of new formulations, or changes in raw material specifications.
    Method Changes in manufacturing processes that have not been reflected in risk assessments.
    Machine Equipment upgrades or maintenance issues that could alter the risk profile.
    Man Insufficient training or changes in personnel that may affect adherence to quality standards.
    Measurement Lapses in monitoring methods that fail to capture new risk factors.
    Environment Changes in the manufacturing environment impacting product quality.

    By categorizing potential causes, teams can strategically focus their investigations on the most likely factors affecting risk assessments.

    Immediate Containment Actions (first 60 minutes)

    Upon identifying symptoms of outdated risk assessments, immediate containment measures are critical to mitigate any potential impact on product quality. Recommended actions include:

    1. Document the Incident: Record all relevant details concerning the quality issue, including time, location, and personnel involved.
    2. Isolate Affected Products: If applicable, quarantine products associated with the potential issue to prevent further complications.
    3. Notify Key Personnel: Ensure that the QA team and relevant stakeholders are informed about the issue to foster swift response and analysis.
    4. Review Current Risk Assessments: Conduct a quick review of related risk assessments and any prior CAPAs to determine if they adequately address the identified issue.

    These rapid actions enable organizations to manage risks immediately while setting the stage for a more thorough investigation.

    Investigation Workflow (data to collect + how to interpret)

    A structured investigation workflow can help uncover the underlying reasons for outdated risk assessments. Key steps in this workflow include:

    1. Data Collection:
      • Gather all related risk assessments, timelines of changes, and related deviation records.
      • Engage stakeholders to gather insights on any known changes in processes or materials.
      • Collect empirical evidence from testing or stability data that may indicate risks.
    2. Data Analysis: Once all relevant data has been collected, analyze the information for patterns or trends. Be vigilant for recurring themes that highlight systemic issues in risk management practices.
    3. Stakeholder Input: Conduct interviews with team members who directly interact with the processes in question. Their perspectives may illuminate important factors affecting the effectiveness of risk assessments.

    This thorough methodology ensures that the investigation is grounded in robust evidence and includes insights from multiple perspectives.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

    To accurately determine the root cause of outdated risk assessments, utilizing appropriate tools is vital. Here are three core methodologies:

    • 5-Why Analysis: Ideal for straightforward issues, this technique digs deep to uncover the underlying cause by asking “why” repeatedly until reaching the root. Use it when clear symptoms are present.
    • Fishbone Diagram (Ishikawa): Best for complex problems involving multiple factors. This tool helps categorize potential causes and visualize relationships between them. Suitable when diverse elements are suspected to contribute to risk assessment inadequacies.
    • Fault Tree Analysis (FTA): An advanced method that assists in systematically analyzing failures by creating a logical diagram of events leading to risks. This tool is beneficial for technical systems where interactions are complex.

    Choosing the right tool depends on the specific problem context, complexity, and available data.

    CAPA Strategy (correction, corrective action, preventive action)

    Once root causes have been identified, establishing an effective Corrective and Preventive Action (CAPA) strategy is necessary. The strategy should encompass:

    1. Correction: Implement immediate fixes to the current issue, such as reinstating compliant processes or stopping production until risk assessments are updated.
    2. Corrective Action: Develop a detailed action plan to resolve the root cause(s). Ensure that affected risk assessments are reviewed and updated accordingly, focusing on processes, materials, and training.
    3. Preventive Action: After addressing the current concerns, establish procedures to prevent recurrence. This may involve regular reviews of risk assessments and updating them according to changes in regulations or internal processes.

    Documenting every step taken in the CAPA process is essential for regulatory compliance and internal accountability.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    To ensure that your risk management efforts remain effective over time, an ongoing control strategy must be in place. Key components include:

    Related Reads

    1. Statistical Process Control (SPC): Utilize SPC tools to monitor critical quality parameters continuously. Implement control charts to help identify trends before they become significant issues.
    2. Sampling Plans: Design and implement sampling strategies that reflect the environmental and operational changes impacting risk assessments. Ensure that sampling is representative of the entire production process.
    3. Alarm Systems: Establish threshold-based alarms or alerts for deviations that exceed normal ranges. This enables proactive responses before issues lead to product quality failures.
    4. Verification: Conduct regular verification of effectiveness against updated risk assessments to ensure that processes remain compliant and risk controls are appropriate.

    This comprehensive control strategy instills a culture of continuous improvement, enhancing overall manufacturing quality.

    Validation / Re-qualification / Change Control impact (when needed)

    It is critical to assess the impact of any changes to risk assessments on validation and re-qualification strategies. Depending on the extent of updates, you may need to:

    • Re-qualify Equipment: If process changes significantly affect product quality or compliance, revisiting equipment qualification may be necessary.
    • Re-validate Processes: Major modifications in processes require thorough validation to ensure that the changes do not compromise product safety or efficacy.
    • Change Control Procedures: Implement robust change controls for any updates to risk assessments. Document why changes were made, detail the assessment that preceded the change, and reference the relevant SOPs.

    Ensuring alignment between risk assessments and validation activities is key to maintaining compliance and quality standards.

    Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

    Maintaining inspection readiness is crucial in the pharmaceutical manufacturing environment. To ensure preparedness, you should have the following documentation readily available:

    • Risk Assessment Records: Document when and how each assessment was performed, including justification for the methodologies chosen.
    • Training Logs: Keep records of training schedules for personnel involved in risk management activities to demonstrate competence.
    • Batch Documentation: Ensure that manufacturing records reflect compliance with updated risk assessments and any subsequent CAPA measures taken.
    • Deviation Reports: Document all deviations and corrections taken. Include actions taken to update risk assessment based on these reports.
    • Audit Trails: Maintain comprehensive audit trails of changes made and the rationale behind them to facilitate transparency during inspections.

    These records not only support compliance but also strengthen your organization’s commitment to quality management.

    FAQs

    What is ICH Q9 in quality risk management?

    ICH Q9 is an international guideline that outlines principles and guidelines for quality risk management in the pharmaceutical industry, providing a framework for risk assessment, risk control, and risk review.

    How often should risk assessments be revisited?

    Risk assessments should be revisited regularly or when significant changes occur in materials, processes, or regulations that could affect product quality.

    What is FMEA in the context of quality risk management?

    Failure Mode and Effects Analysis (FMEA) is a structured approach used to identify potential failure modes in a process and assess their impact, helping to prioritize risks based on their severity and likelihood.

    Why is CAPA important in risk management?

    CAPA is vital for addressing identified risks and their root causes, ensuring ongoing quality improvement and compliance with regulatory standards.

    How can SPC help in quality risk management?

    Statistical Process Control (SPC) enables continuous monitoring of critical quality parameters to identify trends and deviations, helping prevent non-compliance and quality failures.

    What documents are essential for inspection readiness?

    Essential documents include risk assessment records, training logs, batch documentation, deviation reports, and audit trails of any changes made.

    What are the key components of a control strategy?

    A control strategy involves monitoring critical quality parameters, implementing effective sampling plans, setting alarm thresholds, and conducting regular verifications of compliance with updated risk assessments.

    How does change control impact risk assessments?

    Change control ensures that any updates to risk assessments are carefully reviewed, documented, and communicated, maintaining alignment with regulatory requirements and quality standards.

    What tools are available for root cause analysis?

    Common tools for root cause analysis include the 5-Why analysis, Fishbone diagrams, and Fault Tree Analysis, each suited for different types of problems.

    What role does validation play in pharmaceutical QRM?

    Validation confirms that changes resulting from risk assessments do not compromise product quality or safety and that processes remain compliant with established standards.

    If you find our Articles useful
    Add us as preferred source on Google
    Pharma Tip:  How to Set Risk Acceptance Criteria Under ICH Q9
    If you find our Articles useful
    Add us as preferred source on Google